Kane Biotech Inc KNBIF

Primary Symbol: V.KNE

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.

TSXV:KNE - Post by User

Kane Biotech Inc > Progenacare is now listing revyve on their website

<< Previous

Bullboard Posts

Next >>

Comment by francoisl13on Nov 09, 2023 2:06pm

69 Views

Post# 35726650

RE:RE:RE:RE:RE:Progenacare is now listing revyve on their website

Thank you KevinOleary, the quality of your posts are well above average, thanks for sharing your opinions with the community.
P.S. Don't forget to take your pills, you'll feel better.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing